Johnson & Johnson stock price

Johnson & Johnson latest news:


  • 02/05/2018 13:02:27

    Johnson & Johnson falls on report that lawsuits could expose damaging documents

    J&J is facing numerous lawsuits claiming its talc products such as Johnson's Baby Powder caused cancer.        

  • 01/23/2018 15:03:32

    Netflix lifts S&P, Nasdaq; J&J, Procter hold Dow in check

    NEW YORK (Reuters) - U.S. stocks advanced on Tuesday, as strong results from Netflix helped lift the S&P and Nasdaq Composite, but the Dow Industrials were hemmed in by declines in Johnson & Johnson and Procter & Gamble.

  • 01/23/2018 14:32:42

    Netflix and Whirlpool jump while Twitter and J&J fall

    Netflix and Whirlpool rise while Twitter and Johnson & Johnson take losses

  • 01/23/2018 13:12:43

    Johnson & Johnson loses $10.7B after sweeping US tax changes

    Johnson & Johnson reports 4th-quarter loss of $10.71 billion due to charge for tax law changes, higher spending

  • 01/23/2018 11:46:33

    Netflix lifts S&P, Nasdaq; J&J weighs on Dow

    (Reuters) - The S&P and the Nasdaq rose on Tuesday as upbeat earnings from Netflix spurred gains for the highly-valued technology sector, while the blue-chip Dow index came under pressure from declines in Johnson & Johnson and Procter & Gamble.

  • 01/23/2018 11:18:05

    J&J takes $13.6 billion charge related to new U.S. tax law

    (Reuters) - Healthcare conglomerate Johnson & Johnson on Tuesday took a $13.6-billion charge related to the new U.S. tax law and plans to bring back billions of dollars from overseas immediately.

  • 01/23/2018 10:01:42

    Tech and consumer-focused companies rise; Netflix leaps

    U.S. stocks are mostly higher as technology and consumer-focused companies rise but consumer goods makers like Johnson & Johnson take losses

  • 01/23/2018 10:01:14

    Tech and consumer-focused companies rise; Netflix leaps

    U.S. stocks are mixed in early trading Tuesday as consumer-focused companies like Netflix and Amazon climb while household goods makers including Johnson & Johnson and Procter & Gamble sink following disappointing quarterly reports.

  • 01/23/2018 09:53:11

    S&P, Nasdaq lifted by strong earnings from Netflix

    (Reuters) - The S&P and the Nasdaq rose on Tuesday as upbeat earnings from Netflix spurred gains for the highly-valued technology sector, while the Dow came under pressure from declines in Johnson & Johnson and Procter & Gamble.

  • 01/23/2018 09:14:45

    U.S. appeals court upholds ruling invalidating J&J patent on Remicade

    A U.S. appeals court on Tuesday upheld a ruling that invalidated a crucial Johnson & Johnson (JNJ) patent on its blockbuster rheumatoid arthritis drug Remicade, limiting J&J’s ability to seek damages from Pfizer Inc (PFE) over its launch of a lower-cost version of the drug.

  • 01/17/2018 16:22:17

    U.S. court invalidates patent on J&J cancer drug Zytiga

    A U.S. administrative court on Wednesday invalidated a Johnson & Johnson (JNJ) patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions. The Patent Trial and Appeal Board said a Johnson & Johnson (JNJ) patent describing a method of administering Zytiga should not have been granted because the process it described was obvious.

  • 01/09/2018 20:07:35

    Bayer, J&J win reversal of $28 million verdict in Xarelto lawsuit

    (Reuters) - A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson & Johnson of failing to warn of internal bleeding risks of their drug Xarelto, the companies said.

  • 01/02/2018 12:10:44

    FDA issues recall on J&J heart device

    Jan 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday issued a recall of a heart device made by a unit of Johnson & Johnson due to a faulty valve.

  • 12/14/2017 11:21:10

    S&P, Dow flat as healthcare losses offset by tech, media gains

    (Reuters) - The S&P 500 and the Dow were trading flat in early afternoon on Thursday as losses in healthcare stocks such as Johnson & Johnson were offset by gains in shares of technology and consumer discretionary companies.

  • 12/05/2017 12:32:53

    UPDATE 1-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

    Dec 5 (Reuters) - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

  • 12/05/2017 12:01:53

    Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

    - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks by its blockbuster drug Xarelto.

  • 12/05/2017 11:00:22

    Jury orders Bayer, J&J to pay $29 million in Xarelto lawsuit

    A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson (JNJ) to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks by its blockbuster drug Xarelto. The jury slapped the companies, which jointly developed the blood thinner, with $26 million in compensatory and $1.8 million in punitive damages, according to the couple's lawyer.

  • 12/04/2017 00:43:45

    Idorsia to get $230 mln from J&J in latest hypertension deal

    ZURICH, Dec 4 (Reuters) - Idorsia, the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J), will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

  • More trends:

    Johnson ControlsJCI | Jones EnergyJONE | Jones Lang LaSalle IncorporatedJLL | Journal Media GroupJMG | Joy Global Inc.JOY | JP Energy Partners LPJPEP | JPMorgan China Region FundJFC | Jumei International Holding LimitedJMEI | Juniper NetworksJNPR | Jupai Holdings LimitedJP |